All reports
All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports
- 2005 (3) Apply 2005 filter
- 2007 (2) Apply 2007 filter
- 2008 (2) Apply 2008 filter
- 2009 (1) Apply 2009 filter
- 2010 (2) Apply 2010 filter
- 2011 (1) Apply 2011 filter
- 2012 (1) Apply 2012 filter
- 2013 (1) Apply 2013 filter
- 2015 (2) Apply 2015 filter
- 2016 (1) Apply 2016 filter
- 2017 (2) Apply 2017 filter
- 2019 (2) Apply 2019 filter
- (-) Remove Health technology assessment filter Health technology assessment (20)
- Biological and genetic diagnostic tests (1) Apply Biological and genetic diagnostic tests filter
- (-) Remove Cardiovascular Diseases filter Cardiovascular Diseases (20)
- Drugs (1) Apply Drugs filter
- Hematology and transfusion (2) Apply Hematology and transfusion filter
- Medical imaging (1) Apply Medical imaging filter
- Prevention, Screening and vaccination (2) Apply Prevention, Screening and vaccination filter
-
Left ventricular assist devices in the treatment of end-stage heart failure
KCE Reports 264 (2016)
-
Non-invasive markers of subclinical atherosclerosis for predicting a primary cardiovascular event: a rapid systematic review
KCE Reports 244 (2015)
-
Cardiovascular pre-participation screening in young athletes
KCE Reports 241 (2015) About 1 million young Belgians (14-34) are member of a sportsclub, and in addition, many others are practicing a sport outside the structure of a sport organization. As we all know, sport is very good for your health. But, unfortunately, but luckily very seldom, it can lead to a sudden death due to cardiac failure. The authorities already have made a lot of effort to limit the risk for sporters. But can we avoid this kind of shocking events by submitting young sporters, without heart complaints, to a systematic heart examination?
-
Novel serum biomarkers for the prediction of cardiovascular risk
KCE Reports 201 (2013)
-
Catheter ablation of atrial fibrillation
KCE Reports 184 (2012)
-
Transcatheter Aortic Valve Implantation (TAVI): a Health Technology Assessment Update
KCE Reports 163 (2011)
-
Cardiac resynchronisation therapy. A health technology assessment
KCE Reports 145 (2010)
-
Remote monitoring for patients with implanted defibrillators. Technology evaluation and broader regulatory framework
KCE Reports 136 (2010)
-
Use of point-of care devices in patients with oral anticoagulation : a Health Technology Assessment
KCE Reports 117 (2009)
-
Percutaneous heart valve implantation in congenital and degenerative valve disease. A rapid Health Technology Assessment.
KCE Reports 95 (2008)
-
64-Slice computed tomography imaging of coronary arteries in patients suspected for coronary artery disease
KCE Reports 82 (2008)
-
Drug Eluting Stents in Belgium: Health Technology Assessment
KCE Reports 66 (2007)
-
The Implantable Cardioverter Defibrillator: a Health Technology Assessment
KCE Reports 58 (2007)
-
[Natriuretic peptides in the diagnostic work-up of patients with suspected heart failure]
KCE Reports 24 (2005)
-
[Elective endovascular treatment of the abdominal aortic aneurysm (AAA)]
KCE Reports 23 (2005)
-
[Endovascular Treatment of Carotid stenosis]
KCE Reports 13 (2005)
-
Anticoagulants in non-valvular atrial fibrillation
KCE Reports 279 (2016)
-
Static automated external defibrillators for opportunistic use by bystanders
KCE Reports 294 (2017)
-
Statins for the primary prevention of cardiovascular events
KCE Reports 306 (2019) A healthy lifestyle remains the most effective way of avoiding cardiovascular diseases and their consequences. Yet since 2002, the annual number of people who use cholesterol-lowering drugs from the statin family increased from 400,000 to 1,500,000. Currently, 25% of the population aged 40 and above take these drugs. Despite decreases in price due to the fact that all statins now exist in generic form, their total cost still stands at 160 million euros annually.
-
The use of statins in the primary prevention of cardiovascular disease: an online tool for shared-decision making
KCE Reports 324 (2019)